| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9683 | 
      | Human Intestinal Absorption | HIA+ | 0.9476 | 
      | Caco-2 Permeability | Caco2- | 0.5126 | 
      | P-glycoprotein Substrate | Substrate | 0.7862 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.8563 | 
                                                     | Inhibitor | 0.7689 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.5807 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.6061 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7442 | 
      | CYP450 2D6 Substrate | Substrate | 0.8919 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6813 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.9107 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.9278 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9089 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7548 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7745 | 
                                                                    | Inhibitor | 0.7066 | 
      | AMES Toxicity | Non AMES toxic | 0.8093 | 
      | Carcinogens | Non-carcinogens | 0.8836 | 
      | Fish Toxicity | High FHMT | 0.8792 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9544 | 
      | Honey Bee Toxicity | Low HBT | 0.8178 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | II | 0.7409 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6843 |